Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-07-11 00:00:00 ET · period of report 2025-07-09 · accession 0001104659-25-067431 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-11 | 2025-07-09 | RYTM | Smith Hunter C | CFO | S - Sale+OE | $80.48 | -42.1K | 140.3K | -23% | -$3.39M |
| D | 2025-07-11 | 2025-07-09 | RYTM | Smith Hunter C | CFO | M - OptEx | $6.88 | +42.1K | 159.0K | +36% | +$289.8K |
| D | 2025-07-11 | 2025-07-09 | RYTM | Smith Hunter C | CFO | M - OptEx | $0.00 | -42.1K | 28.1K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-09 | S | D | 23,400 | $84.50 | 116,915 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-09 | S | D | 17,113 | $75.38 | 141,922 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $75.01 to $75.70 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-07-09 | M | A | 42,120 | $6.88 | 159,035 | D | — | — | |
| 4 | Common | Common Stock | 2025-07-09 | S | D | 1,607 | $76.17 | 140,315 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $76.17 to $76.18 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Stock Options (Right to Buy) | 2025-07-09 | M | D | 42,120 | $0.00 | 28,088 | D | $6.88 · — to 2027-08-08 | 42,120 Common Stock | (F4) The stock option is fully vested. |